{"id":77924,"date":"2019-11-06T14:04:00","date_gmt":"2019-11-06T14:04:00","guid":{"rendered":"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/"},"modified":"2019-11-06T14:04:00","modified_gmt":"2019-11-06T14:04:00","slug":"els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/","title":{"rendered":"Els medicaments fotosensibilitzants centren la segona fase de la campanya \u201cAtenci\u00f3 Pell 365\u201d impulsada pel COF de Barcelona i l\u2019Hospital Cl\u00ednic"},"content":{"rendered":"<p>\u00a0<br \/>\n\tUn 55% de les persones enquestades durant <strong>&#8220;Atenci\u00f3 Pell 2018&#8221;<\/strong> prenia medicaments fotosensibilitzants -f\u00e0rmacs que augmenten la vulnerabilitat al sol- i, d\u2019aquests, <strong>el 76% no utilitzava sempre protecci\u00f3 solar<\/strong><br \/>\n\tAl llarg de la tardor, els farmac\u00e8utics informaran els pacients sobre <strong>aquest tipus de f\u00e0rmacs<\/strong>, de les <strong>mesures preventives<\/strong> i, en el moment de la dispensaci\u00f3, enganxaran una <strong>etiqueta a l\u2019env\u00e0s del medicament per indicar que \u00e9s fotosensibilitzant<\/strong><br \/>\n\t<strong>\u200b<\/strong>La campanya <strong>\u201cAtenci\u00f3 Pell 365\u201d<\/strong>, sota el lema <strong>\u201cProtegeix-te, perqu\u00e8 cada dia surt el sol\u201d<\/strong>, t\u00e9 per <strong>objectiu de conscienciar la poblaci\u00f3 sobre la import\u00e0ncia de protegir-se del sol tot l\u2019any<\/strong><\/p>\n<p><strong>\u200b<\/strong><\/p>\n<p><em>Barcelona, 6 de novembre de 2019.<\/em> El <strong>Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/strong> (COFB) i l\u2019<strong>Hospital Cl\u00ednic de Barcelona <\/strong>impulsen la segona fase de la campanya <strong>\u201cAtenci\u00f3 Pell 365\u201d <\/strong>que, <strong>coincidint amb la tardor<\/strong>, se centrar\u00e0 en els <strong>medicaments fotosensibilitzants<\/strong> -f\u00e0rmacs que augmenten la nostra vulnerabilitat al sol-. D\u2019aquesta manera, es d\u00f3na continu\u00eftat a la campanya que va comen\u00e7ar a l\u2019estiu sota el lema <strong>\u201cProtegeix-te, perqu\u00e8 cada dia surt el sol\u201d<\/strong>, amb l\u2019<strong>objectiu de conscienciar la poblaci\u00f3 sobre la import\u00e0ncia de protegir-se del sol tot l\u2019any<\/strong>.\u00a0<br \/>\nUn <strong>55% <\/strong>de les persones enquestades durant <strong>&#8220;Atenci\u00f3 Pell 2018&#8221;<\/strong> prenia <strong>medicaments fotosensibilitzants<\/strong>\u00a0 i, d\u2019aquests, <strong>el 76% no utilitzava sempre protecci\u00f3 solar<\/strong>, dades que evidencien la necessitat d\u2019incidir en la divulgaci\u00f3 d\u2019aquest tipus de f\u00e0rmacs. En aquest sentit, <strong>els m\u00e9s de 413 farmac\u00e8utics (339 farm\u00e0cies) participants en la campanya<\/strong>, formats pr\u00e8viament en aquest camp, informaran els usuaris sobre <strong>l&#8217;exist\u00e8ncia de medicaments fotosensibilitzants<\/strong> -alguns s&#8217;utilitzen en casos com el <strong>dolor<\/strong> o la <strong>inflamaci\u00f3<\/strong>, el <strong>colesterol alt<\/strong>, l&#8217;<strong>al\u00b7l\u00e8rgia<\/strong>, l&#8217;<strong>insomni<\/strong>, la <strong>hipertensi\u00f3 arterial<\/strong>, l&#8217;<strong>acidesa estomacal<\/strong>, les <strong>infeccions bacterianes<\/strong>, la <strong>depressi\u00f3<\/strong> o l&#8217;<strong>acne<\/strong>&#8211; i de les <strong>mesures preventives<\/strong> que s&#8217;han de prendre per tal de <strong>minimitzar els seus efectes perjudicials per a la nostra pell<\/strong>.<\/p>\n<p><strong>Els materials de la campanya<\/strong><\/p>\n<p><strong>\u201cAtenci\u00f3 Pell 365\u201d<\/strong>, que compta amb el patrocini dels laboratoris Av\u00e8ne, Ladival i La Roche-Posay, ha posat a disposici\u00f3 dels farmac\u00e8utics participants diversos <strong>materials divulgatius<\/strong>: un <strong>vinil<\/strong> que podran penjar a la farm\u00e0cia i <strong>fulletons<\/strong> per als usuaris amb informaci\u00f3 sobre <strong>com aplicar el protector solar<\/strong>, <strong>quins medicaments s\u00f3n fotosensibilitzants<\/strong>, els <strong>efectes de la radiaci\u00f3 del sol<\/strong> sobre la pell i diferents <strong>maneres de protegir-se del sol<\/strong>.\u00a0<br \/>\nA m\u00e9s, com a novetat, en aquesta segona fase, els farmac\u00e8utics disposaran d&#8217;unes <strong>etiquetes que podran enganxar a l\u2019env\u00e0s del medicament a l\u2019hora de dispensar-lo per indicar que \u00e9s fotosensibilitzant, per refor\u00e7ar la intervenci\u00f3 farmac\u00e8utica i per recordar que el pacient s\u2019ha de protegir per evitar les reaccions de fotosensibilitat mentre hagi de prendre el f\u00e0rmac&#8230;<\/strong><\/p>\n<p><strong>Educaci\u00f3 sanit\u00e0ria en la dispensaci\u00f3 i indicaci\u00f3<\/strong><\/p>\n<p>En el moment de la <strong>dispensaci\u00f3 i indicaci\u00f3 de medicaments fotosensibilitzants<\/strong>, els farmac\u00e8utics poden realitzar una important <strong>tasca d\u2019educaci\u00f3 sanit\u00e0ria<\/strong> informant el pacient que el medicament que se li dispensar\u00e0 <strong>tindr\u00e0 aquestes caracter\u00edstiques<\/strong>, preguntant-li el grau d&#8217;exposici\u00f3 espec\u00edfic al sol (si fa activitats a l&#8217;exterior, si utilitza protecci\u00f3 f\u00edsica&#8230;);\u00a0 detectant reaccions adverses; valorant el millor moment per a l&#8217;inici del tractament (si es pot) i situant, quan sigui possible, la presa del medicament a la nit.<br \/>\nAix\u00ed mateix, per prevenir les <strong>reaccions de fotosensibilitat<\/strong> indu\u00efdes per f\u00e0rmacs els farmac\u00e8utics <strong>recomanaran evitar l&#8217;exposici\u00f3 al sol <\/strong>(quan sigui possible), l&#8217;\u00fas de <strong>protecci\u00f3 f\u00edsica<\/strong> (roba, ulleres, etc.), l&#8217;\u00fas de <strong>protecci\u00f3 solar<\/strong> sempre que se surti al carrer en zones exposades i l&#8217;\u00fas de <strong>fotoprotecci\u00f3 oral complement\u00e0ria, mai substitut\u00f2ria<\/strong>.<\/p>\n<p><strong>Campanya \u201cAtenci\u00f3 Pell 365\u201d<\/strong><\/p>\n<p>La <strong>campanya d\u2019educaci\u00f3 sanit\u00e0ria \u201cAtenci\u00f3 Pell 365\u201d<\/strong> t\u00e9 per <strong>objectius<\/strong> fomentar la idea que <strong>protegir-se del sol<\/strong> \u00e9s un <strong>h\u00e0bit atempora<\/strong>l, no estacional; aconsellar sobre l\u2019<strong>\u00fas correcte de protectors solars<\/strong>; promoure <strong>h\u00e0bits d\u2019exposici\u00f3 saludables<\/strong>; informar sobre els <strong>efectes de les diferents radiacions<\/strong> i, en definitiva, donar <strong>consells de salut als usuaris perqu\u00e8 s\u00e0piguen com protegir-se del sol adequadament durant tot l\u2019any<\/strong>.\u00a0\u00a0<br \/>\nAquests objectius s\u00f3n comuns a les <strong>quatre fases<\/strong> en qu\u00e8 es divideix la campanya, que s\u00f3n les seg\u00fcents: <strong>etiquetatge, quantitat, aplicacions i textures dels protectors solars<\/strong> (estiu); <strong>medicaments fotosensibilitzants<\/strong> (tardor); <strong>exposici\u00f3 invisible<\/strong> (hivern) i <strong>protecci\u00f3 f\u00edsica i h\u00e0bits d&#8217;exposici\u00f3<\/strong> (primavera).<\/p>\n<p>\n<strong>\u00a0Amb el patrocini de:<\/strong><\/p>\n<p><strong><\/strong><\/p>\n<p>\u00a0<\/p>\n<p>\u00a0Un 55% de les persones enquestades durant &#8220;Atenci\u00f3 Pell 2018&#8221; prenia medicaments fotosensibilitzants -f\u00e0rmacs que augmenten la vulnerabilitat al sol- i, d\u2019aquests, el 76% no utilitzava sempre protecci\u00f3 solar<br \/>\n\tAl llarg de la tardor, els farmac\u00e8utics informaran els pacients sobre aquest tipus de f\u00e0rmacs, de les mesures preventives i, en el moment de la dispensaci\u00f3, enganxaran una etiqueta a l\u2019env\u00e0s del medicament per indicar que \u00e9s fotosensibilitzant<br \/>\n\t\u200bLa campanya \u201cAtenci\u00f3 Pell 365\u201d, sota el lema \u201cProtegeix-te, perqu\u00e8 cada dia surt el sol\u201d, t\u00e9 per objectiu de conscienciar la poblaci\u00f3 sobre la import\u00e0ncia de protegir-se del sol tot l\u2019any<\/p>\n<p>\u200b<\/p>\n<p>Barcelona, 6 de novembre de 2019. El Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) i l\u2019Hospital Cl\u00ednic de Barcelona impulsen la segona fase de la campanya \u201cAtenci\u00f3 Pell 365\u201d que, coincidint amb la tardor, se centrar\u00e0 en els medicaments fotosensibilitzants -f\u00e0rmacs que augmenten la nostra vulnerabilitat al sol-. D\u2019aquesta manera, es d\u00f3na continu\u00eftat a la campanya que va comen\u00e7ar a l\u2019estiu sota el lema \u201cProtegeix-te, perqu\u00e8 cada dia surt el sol\u201d, amb l\u2019objectiu de conscienciar la poblaci\u00f3 sobre la import\u00e0ncia de protegir-se del sol tot l\u2019any.\u00a0<br \/>\nUn 55% de les persones enquestades durant &#8220;Atenci\u00f3 Pell 2018&#8221; prenia medicaments fotosensibilitzants\u00a0 i, d\u2019aquests, el 76% no utilitzava sempre protecci\u00f3 solar, dades que evidencien la necessitat d\u2019incidir en la divulgaci\u00f3 d\u2019aquest tipus de f\u00e0rmacs. En aquest sentit, els m\u00e9s de 413 farmac\u00e8utics (339 farm\u00e0cies) participants en la campanya, formats pr\u00e8viament en aquest camp, informaran els usuaris sobre l&#8217;exist\u00e8ncia de medicaments fotosensibilitzants -alguns s&#8217;utilitzen en casos com el dolor o la inflamaci\u00f3, el colesterol alt, l&#8217;al\u00b7l\u00e8rgia, l&#8217;insomni, la hipertensi\u00f3 arterial, l&#8217;acidesa estomacal, les infeccions bacterianes, la depressi\u00f3 o l&#8217;acne- i de les mesures preventives que s&#8217;han de prendre per tal de minimitzar els seus efectes perjudicials per a la nostra pell.<\/p>\n<p>Els materials de la campanya<\/p>\n<p>\u201cAtenci\u00f3 Pell 365\u201d, que compta amb el patrocini dels laboratoris Av\u00e8ne, Ladival i La Roche-Posay, ha posat a disposici\u00f3 dels farmac\u00e8utics participants diversos materials divulgatius: un vinil que podran penjar a la farm\u00e0cia i fulletons per als usuaris amb informaci\u00f3 sobre com aplicar el protector solar, quins medicaments s\u00f3n fotosensibilitzants, els efectes de la radiaci\u00f3 del sol sobre la pell i diferents maneres de protegir-se del sol.\u00a0<br \/>\nA m\u00e9s, com a novetat, en aquesta segona fase, els farmac\u00e8utics disposaran d&#8217;unes etiquetes que podran enganxar a l\u2019env\u00e0s del medicament a l\u2019hora de dispensar-lo per indicar que \u00e9s fotosensibilitzant, per refor\u00e7ar la intervenci\u00f3 farmac\u00e8utica i per recordar que el pacient s\u2019ha de protegir per evitar les reaccions de fotosensibilitat mentre hagi de prendre el f\u00e0rmac&#8230;<\/p>\n<p>Educaci\u00f3 sanit\u00e0ria en la dispensaci\u00f3 i indicaci\u00f3<\/p>\n<p>En el moment de la dispensaci\u00f3 i indicaci\u00f3 de medicaments fotosensibilitzants, els farmac\u00e8utics poden realitzar una important tasca d\u2019educaci\u00f3 sanit\u00e0ria informant el pacient que el medicament que se li dispensar\u00e0 tindr\u00e0 aquestes caracter\u00edstiques, preguntant-li el grau d&#8217;exposici\u00f3 espec\u00edfic al sol (si fa activitats a l&#8217;exterior, si utilitza protecci\u00f3 f\u00edsica&#8230;);\u00a0 detectant reaccions adverses; valorant el millor moment per a l&#8217;inici del tractament (si es pot) i situant, quan sigui possible, la presa del medicament a la nit.<br \/>\nAix\u00ed mateix, per prevenir les reaccions de fotosensibilitat indu\u00efdes per f\u00e0rmacs els farmac\u00e8utics recomanaran evitar l&#8217;exposici\u00f3 al sol (quan sigui possible), l&#8217;\u00fas de protecci\u00f3 f\u00edsica (roba, ulleres, etc.), l&#8217;\u00fas de protecci\u00f3 solar sempre que se surti al carrer en zones exposades i l&#8217;\u00fas de fotoprotecci\u00f3 oral complement\u00e0ria, mai substitut\u00f2ria.<\/p>\n<p>Campanya \u201cAtenci\u00f3 Pell 365\u201d<\/p>\n<p>La campanya d\u2019educaci\u00f3 sanit\u00e0ria \u201cAtenci\u00f3 Pell 365\u201d t\u00e9 per objectius fomentar la idea que protegir-se del sol \u00e9s un h\u00e0bit atemporal, no estacional; aconsellar sobre l\u2019\u00fas correcte de protectors solars; promoure h\u00e0bits d\u2019exposici\u00f3 saludables; informar sobre els efectes de les diferents radiacions i, en definitiva, donar consells de salut als usuaris perqu\u00e8 s\u00e0piguen com protegir-se del sol adequadament durant tot l\u2019any.\u00a0\u00a0<br \/>\nAquests objectius s\u00f3n comuns a les quatre fases en qu\u00e8 es divideix la campanya, que s\u00f3n les seg\u00fcents: etiquetatge, quantitat, aplicacions i textures dels protectors solars (estiu); medicaments fotosensibilitzants (tardor); exposici\u00f3 invisible (hivern) i protecci\u00f3 f\u00edsica i h\u00e0bits d&#8217;exposici\u00f3 (primavera).<\/p>\n<p>\u00a0Amb el patrocini de:<\/p>\n<p>\u00a0\u00a0\u00a0COFB.ORG<\/p>","protected":false},"excerpt":{"rendered":"<p>\u00a0 Un 55% de les persones enquestades durant &#8220;Atenci\u00f3 Pell 2018&#8221; prenia medicaments fotosensibilitzants -f\u00e0rmacs que augmenten la vulnerabilitat al sol- i, d\u2019aquests, el 76% no utilitzava sempre protecci\u00f3 solar Al llarg de la tardor, els farmac\u00e8utics informaran els pacients sobre aquest tipus de f\u00e0rmacs, de les mesures preventives i, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":77166,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1060,1066],"tags":[],"class_list":["post-77924","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notes-premsa","category-sense-categoria-ca"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Els medicaments fotosensibilitzants centren la segona fase de la campanya \u201cAtenci\u00f3 Pell 365\u201d impulsada pel COF de Barcelona i l\u2019Hospital Cl\u00ednic - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Els medicaments fotosensibilitzants centren la segona fase de la campanya \u201cAtenci\u00f3 Pell 365\u201d impulsada pel COF de Barcelona i l\u2019Hospital Cl\u00ednic - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"\u00a0 Un 55% de les persones enquestades durant &#8220;Atenci\u00f3 Pell 2018&#8221; prenia medicaments fotosensibilitzants -f\u00e0rmacs que augmenten la vulnerabilitat al sol- i, d\u2019aquests, el 76% no utilitzava sempre protecci\u00f3 solar Al llarg de la tardor, els farmac\u00e8utics informaran els pacients sobre aquest tipus de f\u00e0rmacs, de les mesures preventives i, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-06T14:04:00+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Els medicaments fotosensibilitzants centren la segona fase de la campanya \u201cAtenci\u00f3 Pell 365\u201d impulsada pel COF de Barcelona i l\u2019Hospital Cl\u00ednic\",\"datePublished\":\"2019-11-06T14:04:00+00:00\",\"dateModified\":\"2019-11-06T14:04:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/\"},\"wordCount\":1494,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2019\/11\/4c3a1d12-9bc0-4c0f-ba21-108b5bbeccff-FCME95-scaled.jpeg\",\"articleSection\":[\"Notes de premsa\"],\"inLanguage\":\"ca\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/\",\"name\":\"Els medicaments fotosensibilitzants centren la segona fase de la campanya \u201cAtenci\u00f3 Pell 365\u201d impulsada pel COF de Barcelona i l\u2019Hospital Cl\u00ednic - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2019\/11\/4c3a1d12-9bc0-4c0f-ba21-108b5bbeccff-FCME95-scaled.jpeg\",\"datePublished\":\"2019-11-06T14:04:00+00:00\",\"dateModified\":\"2019-11-06T14:04:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2019\/11\/4c3a1d12-9bc0-4c0f-ba21-108b5bbeccff-FCME95-scaled.jpeg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2019\/11\/4c3a1d12-9bc0-4c0f-ba21-108b5bbeccff-FCME95-scaled.jpeg\",\"width\":2560,\"height\":1591},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Els medicaments fotosensibilitzants centren la segona fase de la campanya \u201cAtenci\u00f3 Pell 365\u201d impulsada pel COF de Barcelona i l\u2019Hospital Cl\u00ednic\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Els medicaments fotosensibilitzants centren la segona fase de la campanya \u201cAtenci\u00f3 Pell 365\u201d impulsada pel COF de Barcelona i l\u2019Hospital Cl\u00ednic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/","og_locale":"ca_ES","og_type":"article","og_title":"Els medicaments fotosensibilitzants centren la segona fase de la campanya \u201cAtenci\u00f3 Pell 365\u201d impulsada pel COF de Barcelona i l\u2019Hospital Cl\u00ednic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"\u00a0 Un 55% de les persones enquestades durant &#8220;Atenci\u00f3 Pell 2018&#8221; prenia medicaments fotosensibilitzants -f\u00e0rmacs que augmenten la vulnerabilitat al sol- i, d\u2019aquests, el 76% no utilitzava sempre protecci\u00f3 solar Al llarg de la tardor, els farmac\u00e8utics informaran els pacients sobre aquest tipus de f\u00e0rmacs, de les mesures preventives i, [&hellip;]","og_url":"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2019-11-06T14:04:00+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"7 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Els medicaments fotosensibilitzants centren la segona fase de la campanya \u201cAtenci\u00f3 Pell 365\u201d impulsada pel COF de Barcelona i l\u2019Hospital Cl\u00ednic","datePublished":"2019-11-06T14:04:00+00:00","dateModified":"2019-11-06T14:04:00+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/"},"wordCount":1494,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2019\/11\/4c3a1d12-9bc0-4c0f-ba21-108b5bbeccff-FCME95-scaled.jpeg","articleSection":["Notes de premsa"],"inLanguage":"ca"},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/","url":"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/","name":"Els medicaments fotosensibilitzants centren la segona fase de la campanya \u201cAtenci\u00f3 Pell 365\u201d impulsada pel COF de Barcelona i l\u2019Hospital Cl\u00ednic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2019\/11\/4c3a1d12-9bc0-4c0f-ba21-108b5bbeccff-FCME95-scaled.jpeg","datePublished":"2019-11-06T14:04:00+00:00","dateModified":"2019-11-06T14:04:00+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2019\/11\/4c3a1d12-9bc0-4c0f-ba21-108b5bbeccff-FCME95-scaled.jpeg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2019\/11\/4c3a1d12-9bc0-4c0f-ba21-108b5bbeccff-FCME95-scaled.jpeg","width":2560,"height":1591},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2019\/11\/06\/els-medicaments-fotosensibilitzants-centren-la-segona-fase-de-la-campanya-atencio-pell-365-impulsada-pel-cof-de-barcelona-i-lhospital-clinic-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Els medicaments fotosensibilitzants centren la segona fase de la campanya \u201cAtenci\u00f3 Pell 365\u201d impulsada pel COF de Barcelona i l\u2019Hospital Cl\u00ednic"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2019\/11\/4c3a1d12-9bc0-4c0f-ba21-108b5bbeccff-FCME95-scaled.jpeg",2560,1591,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2019\/11\/4c3a1d12-9bc0-4c0f-ba21-108b5bbeccff-FCME95-150x150.jpeg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2019\/11\/4c3a1d12-9bc0-4c0f-ba21-108b5bbeccff-FCME95-300x186.jpeg",300,186,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2019\/11\/4c3a1d12-9bc0-4c0f-ba21-108b5bbeccff-FCME95-768x477.jpeg",768,477,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2019\/11\/4c3a1d12-9bc0-4c0f-ba21-108b5bbeccff-FCME95-1024x636.jpeg",1024,636,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2019\/11\/4c3a1d12-9bc0-4c0f-ba21-108b5bbeccff-FCME95-1536x954.jpeg",1536,954,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2019\/11\/4c3a1d12-9bc0-4c0f-ba21-108b5bbeccff-FCME95-2048x1273.jpeg",2048,1273,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2019\/11\/4c3a1d12-9bc0-4c0f-ba21-108b5bbeccff-FCME95-18x12.jpeg",18,12,true]},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"\u00a0 Un 55% de les persones enquestades durant &#8220;Atenci\u00f3 Pell 2018&#8221; prenia medicaments fotosensibilitzants -f\u00e0rmacs que augmenten la vulnerabilitat al sol- i, d\u2019aquests, el 76% no utilitzava sempre protecci\u00f3 solar Al llarg de la tardor, els farmac\u00e8utics informaran els pacients sobre aquest tipus de f\u00e0rmacs, de les mesures preventives i, [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77924","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=77924"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/77924\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/77166"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=77924"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=77924"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=77924"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}